p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60.
暂无分享,去创建一个
[1] R. Tjian,et al. Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators , 1994, Cell.
[2] R. Tjian,et al. Drosophila TFIIA directs cooperative DNA binding with TBP and mediates transcriptional activation. , 1994, Genes & development.
[3] P. Jeffrey,et al. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. , 1994, Science.
[4] R. Tjian,et al. TBP-TAF complexes: selectivity factors for eukaryotic transcription. , 1994, Current opinion in cell biology.
[5] A. Levine,et al. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. , 1994, Genes & development.
[6] C. Harris,et al. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[7] R. Tjian,et al. A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[8] C. Harris,et al. p53: at the crossroads of molecular carcinogenesis and risk assessment. , 1993, Science.
[9] R. Tjian,et al. Cloning and expression of Drosophila TAFII60 and human TAFII70 reveal conserved interactions with other subunits of TFIID. , 1993, The EMBO journal.
[10] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[11] S. Elledge,et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.
[12] R. Tjian,et al. Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB , 1993, Cell.
[13] X. Chen,et al. Cooperative DNA binding of p53 with TFIID (TBP): a possible mechanism for transcriptional activation. , 1993, Genes & development.
[14] M. Botchan,et al. The acidic transcriptional activation domains of VP16 and p53 bind the cellular replication protein A and stimulate in vitro BPV-1 DNA replication , 1993, Cell.
[15] C. Miller,et al. The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription , 1993, Molecular and cellular biology.
[16] Bert Vogelstein,et al. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 , 1993, Nature.
[17] C. Ingles,et al. Direct interaction between the transcriptional activation domain of human p53 and the TATA box-binding protein. , 1993, The Journal of biological chemistry.
[18] C. Finlay,et al. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth , 1993, Molecular and cellular biology.
[19] G. Zambetti,et al. Wild-type p53 binds to the TATA-binding protein and represses transcription. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[20] P. Friedman,et al. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. , 1992, Genes & development.
[21] Qiang Zhou,et al. Holo-TFIID supports transcriptional stimulation by diverse activators and from a TATA-less promoter. , 1992, Genes & development.
[22] P. Friedman,et al. Wild-type p53 activates transcription in vitro , 1992, Nature.
[23] P. Meltzer,et al. Amplification of a gene encoding a p53-associated protein in human sarcomas , 1992, Nature.
[24] A. Levine,et al. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.
[25] K. Kinzler,et al. Oncogenic forms of p53 inhibit p53-regulated gene expression , 1992 .
[26] T. Unger,et al. p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer. , 1992, The EMBO journal.
[27] R. Tjian,et al. Coactivators for a proline-rich activator purified from the multisubunit human TFIID complex. , 1991, Genes & development.
[28] R. Tjian,et al. Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation , 1991, Cell.
[29] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[30] D. George,et al. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. , 1991, The EMBO journal.
[31] S. Fields,et al. Presence of a potent transcription activating sequence in the p53 protein. , 1990, Science.
[32] G. Lozano,et al. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. , 1990, Science.
[33] Robert Tjian,et al. Mechanism of transcriptional activation by Sp1: Evidence for coactivators , 1990, Cell.
[34] Michael R. Green,et al. Transcription activation by the adenovirus E1a protein , 1989, Nature.
[35] R. Roeder,et al. Factors involved in specific transcription by human RNA polymerase II: analysis by a rapid and quantitative in vitro assay. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[36] R. Roeder,et al. Eukaryotic gene transcription with purified components. , 1983, Methods in enzymology.